Recent Advances in the Management of Non-Melanoma Skin Cancers - Episode 6

Real-World Data of Cemiplimab in Patients with Advanced cSCC

Dr Khushalani provides insights into real-world data that was recently discussed at ESMO 2022 assessing the use of cemiplimab in patients with advanced cSCC.

EP. 1: Overview of Cutaneous Squamous Cell Carcinoma (cSCC)
EP. 2: Treatment Options for Patients with cSCC in the Neoadjuvant Setting
EP. 3: Current Treatment Options for Patients with Advanced Cutaneous Squamous Cell Carcinoma (cSCC)
EP. 4: Review of Updated Efficacy and Safety Data from the EMPOWER-CSCC-1 Trial
EP. 5: Role of Cemiplimab in the Neoadjuvant Setting for Patients with cSCC
Now Viewing
EP. 6: Real-World Data of Cemiplimab in Patients with Advanced cSCC
EP. 7: Investigational Agents for the Treatment of Advanced cSCC
EP. 8: An Overview of Advanced Basal Cell Carcinoma (BCC) and Currently Available Treatment Options
EP. 9: Future Perspectives in cSCC
EP. 10: Treatment Options for Patients with Advanced Basal Cell Carcinoma (BCC)
EP. 11: Looking Ahead: Unmet Needs for the Treatment of BCC